Abstract
Introduction/Objectives
Previous studies have shown conflicting results regarding the association between hypovitaminosis D and non-alcoholic fatty liver disease (NAFLD). The aim of this study is to explore the individual and combined effect of hypovitaminosis D and metabolic syndrome (MS) on NAFLD.
Materials and methods
In this cross-sectional study, 874 subjects were enrolled. 25(OH)D was assessed by a sequential competitive immuno-fluoro-assay method. The Fatty Liver Index (FLI) was used for NAFLD screening. Binary logistic regression and additive interaction were performed to investigate the association between vitamin D status, MS and NAFLD.
Results
Severe vitamin D deficiency was found to be positively related to NAFLD, with a higher risk in women than in men (OR = 6.4, 95% CI [2.8-15], p < 0.0001 vs. OR = 5.8, 95% CI [1.9-17.7], p = 0.002). In men, this association was partially masked by obesity. The additive interaction with MS was significant in women but not in men, the relative excess risk due to interaction was of 7.2, 95% CI [1.3-12.9], p = 0.02), the attributable proportion due to the combined effect was of 0.6, 95% CI [0.4-0.8], p < 0.0001. The interaction mechanism is synergistic; the synergy index: was of 2.9, 95% CI [1.6-5.3], p = 0.0006.
Conclusion
A positive association has been found between severe vitamin D deficiency and NAFLD. Moreover, an excess risk in women combining both MS and severe vitamin D deficiency was quantified.
Similar content being viewed by others
References
Sangouni AA, Ghavamzadeh S, Jamalzehi A. A narrative review on effects of vitamin D on main risk factors and severity of non-alcoholic fatty liver disease. Diabetes Metab Syndr Clin Res Rev. 2019;13:2260–5.
Chen L-W, Chien C-H, Kuo S-F, et al. Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. BMC Gastroenterol. 2019;19:126.
Hao Y, Ma X, Luo Y, et al. Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol Sin. 2014;35:1150–6.
Jablonski KL, Jovanovicha A, Holmenb J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2012;23:792–8.
Bhatt SP, Nigam P, Misra A, et al. Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in North India. Atherosclerosis. 2013;230:157–63.
Park D, Kwon H, Oh S, et al. Is vitamin D an independent risk factor of nonalcoholic fatty liver disease? : A cross-sectional study of the healthy population. J Korean Med. 2017;32:95.
Afarideh M, Ghajar A, Noshad S, et al. Serum 25-hydroxyvitamin D, non-alcoholic fatty liver disease and type 2 diabetes. Nutr Metab Cardiovasc Dis. 2017;27:93–5.
Seo JA, Eun CR, Cho H, et al. Low vitamin D status is associated with nonalcoholic fatty liver disease independent of visceral obesity in Korean adults. PLoS One. 2013;8:e75197.
Chung GE, Kim D, Kwak M, et al. The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2016;22:146–51.
Barchetta I, Angelico F, Ben M, et al. Strong association between non-alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85.
Eliades M. Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol. 2015;21:1718.
Zhai H-L, Wang N-J, Han B, et al. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (survey on prevalence in East China for metabolic diseases and risk factors (SPECT-China)). Br J Nutr. 2016;115:1352–9.
Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34:e118–27.
Nelson JE, Roth C, Wilson L, et al. Vitamin D deficiency is associated with increased risk of non-alcoholic Steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-κB? Am J Gastroenterol. 2016;111:852–63.
Targher G, Scorletti E, Mantovani A, et al. Nonalcoholic fatty liver disease and reduced serum vitamin D 3 levels. Metab Syndr Relat Disord. 2013;11:217–28.
Eliades M, Spyrou E. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38:246–54.
Pacifico L, Osborn JF, Bonci E, et al. Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables. Mini-Rev Med Chem. 2019;19:310–32.
Hong HC, Lee JS, Choi HY, et al. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and nutrition examination survey. Metabolism. 2013;62:1305–12.
WHO | Physical status: the use and interpretation of anthropometry, WHO, 1995. http://www.who.int/childgrowth/publications/physical_status/en/ (consulté le août 19, 2018).
Clearfield MB. The National Cholesterol Education Program Adult Treatment Panel III guidelines. p. 5.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Ha Y, Hwang S, Rim K. The association between vitamin D insufficiency and nonalcoholic fatty liver disease: a population-based study. Nutrients. 2017;9:806.
Bachir Cherif A, Temmar M, Bennouar S, et al. Effect of vitamin D on the variability of blood pressure in premenopausal and menopausal hypertensive women in the area of Blida (Algeria). Ann Cardiol Angéiologie. 2018;67:191–7.
Vigna L, Cassinelli L, Tirelli AS, et al. 25(OH)D levels in relation to gender, overweight, insulin resistance, and inflammation in a cross-sectional cohort of northern Italian workers: evidence in support of preventive health care programs. J Am Coll Nutr. 2017;36:253–60.
Andersson T, Alfredsson L, Källberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–9.
Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601–13.
Zelber-Sagi S, Zur R, Thurm T, et al. Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population. Ann Hepatol. 2019;18:578–84.
Hyppönen E, Boucher BJ. Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities. Nutr Rev. 2018;76:678–92.
Pourshahidi LK. Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc. 2015;74:115–24.
Lu Z, Pan X, Hu Y, et al. Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women. Clin Exp Pharmacol Physiol. 2015;42:139–45.
Lee SM, Jun DW, Cho YK, et al. Vitamin D deficiency in non-alcoholic fatty liver disease: the chicken or the egg? Clin Nutr. 2017;36:191–7.
Acknowledgements
We wholeheartedly thank all patients and subjects for their generous participation in the present work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bennouar, S., Cherif, A.B., Kessira, A. et al. Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease. J Diabetes Metab Disord 20, 1309–1317 (2021). https://doi.org/10.1007/s40200-021-00857-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-021-00857-5